Literature DB >> 1343766

Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome.

P Oxholm1, T E Daniels, K Bendtzen.   

Abstract

The presence and distribution of 7 cytokines was examined immunohistologically in labial salivary gland (LSG) specimens from patients with primary Sjögren's syndrome (SS) and control subjects. The cytokines interleukin (IL)-1 beta IL-6, tumor necrosis factor (TNF) alpha and interferon (IFN) gamma were identified in defined parts of LSG from patients but not in the corresponding parts of control glands: (a) LSG acinar epithelium expressed IL-1 beta, (b) blood vessels located in both normal LSG stroma and within lymphocytic infiltrates expressed IL-1 beta, IL-6 and IFN gamma, and (c) lymphocytic infiltrates expressed IL-1 beta, IL-6 and TNF alpha. All four cytokines were expressed by salivary ducts within both patient and control specimens, but with generally greater intensity in patients. IL-1 alpha, IL-4 and TNF beta (lymphotoxin) could not be detected in any of the specimens from patients or controls. The locations of cytokines in LSG suggests possible mechanisms of immunologically mediated parenchymal damage in primary SS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1343766     DOI: 10.3109/08916939209148458

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  14 in total

Review 1.  Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.

Authors:  M R Kok; B J Baum; P P Tak; S R Pillemer
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  P2X7 receptor activation induces inflammatory responses in salivary gland epithelium.

Authors:  Lucas T Woods; Jean M Camden; Josef M Batek; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-08       Impact factor: 4.249

3.  Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome.

Authors:  R Matsumura; K Umemiya; T Goto; T Nakazawa; M Kagami; H Tomioka; E Tanabe; T Sugiyama; M Sueishi
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

4.  Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.

Authors:  Sreedevi Chinthamani; Olutayo Odusanwo; Nandini Mondal; Joel Nelson; Sriram Neelamegham; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-28       Impact factor: 4.249

5.  Expression of pro-inflammatory TACE-TNF-α-amphiregulin axis in Sjögren's syndrome salivary glands.

Authors:  Margherita Sisto; Sabrina Lisi; Dario Domenico Lofrumento; Giuseppe Ingravallo; Vincenzo Mitolo; Massimo D'Amore
Journal:  Histochem Cell Biol       Date:  2010-09-02       Impact factor: 4.304

Review 6.  Vth International Symposium on Sjögren's syndrome. Clinical aspects and therapy.

Authors:  R I Fox
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

7.  Targeted TNF-α Overexpression Drives Salivary Gland Inflammation.

Authors:  A Limaye; B E Hall; L Zhang; A Cho; M Prochazkova; C Zheng; M Walker; F Adewusi; P D Burbelo; Z J Sun; I S Ambudkar; J C Dolan; B L Schmidt; A B Kulkarni
Journal:  J Dent Res       Date:  2019-04-08       Impact factor: 6.116

Review 8.  Cytokines in Sjögren's syndrome.

Authors:  N Roescher; P P Tak; G G Illei
Journal:  Oral Dis       Date:  2009-06-10       Impact factor: 3.511

9.  Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line.

Authors:  Olga J Baker; Jean M Camden; Robert S Redman; Jonathan E Jones; Cheikh I Seye; Laurie Erb; Gary A Weisman
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-03       Impact factor: 4.249

10.  Anti-inflammatory effect of peroxisome proliferator-activated receptor-γ (PPAR-γ) on non-obese diabetic mice with Sjogren's syndrome.

Authors:  Xiaomei Li; Bei Xu; Yiping Wang; Li Wei
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.